PL3829611T3 - Preparat nutraceutyczny do kontroli nadciśnienia tętniczego - Google Patents

Preparat nutraceutyczny do kontroli nadciśnienia tętniczego

Info

Publication number
PL3829611T3
PL3829611T3 PL19758813.0T PL19758813T PL3829611T3 PL 3829611 T3 PL3829611 T3 PL 3829611T3 PL 19758813 T PL19758813 T PL 19758813T PL 3829611 T3 PL3829611 T3 PL 3829611T3
Authority
PL
Poland
Prior art keywords
control
arterial hypertension
nutraceutical formulation
nutraceutical
formulation
Prior art date
Application number
PL19758813.0T
Other languages
English (en)
Inventor
Mauro Rissa
Original Assignee
Pharmanutrition R&D S.r.l.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmanutrition R&D S.r.l. filed Critical Pharmanutrition R&D S.r.l.
Publication of PL3829611T3 publication Critical patent/PL3829611T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Botany (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL19758813.0T 2018-08-01 2019-08-01 Preparat nutraceutyczny do kontroli nadciśnienia tętniczego PL3829611T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102018000007747A IT201800007747A1 (it) 2018-08-01 2018-08-01 Formulazione nutraceutica per il controllo dell’ipertensione arteriosa da lieve a moderata
PCT/IB2019/056567 WO2020026187A1 (en) 2018-08-01 2019-08-01 Nutraceutical formulation for the control of arterial hypertension

Publications (1)

Publication Number Publication Date
PL3829611T3 true PL3829611T3 (pl) 2023-03-20

Family

ID=63965881

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19758813.0T PL3829611T3 (pl) 2018-08-01 2019-08-01 Preparat nutraceutyczny do kontroli nadciśnienia tętniczego

Country Status (5)

Country Link
EP (1) EP3829611B1 (pl)
ES (1) ES2933982T3 (pl)
IT (1) IT201800007747A1 (pl)
PL (1) PL3829611T3 (pl)
WO (1) WO2020026187A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000015007A1 (it) 2020-06-23 2021-12-23 Bios Line S P A Formulazione orale a base di vitamina d3, acido ascorbico e sali di magnesio per uso come integratore alimentare
US11826346B2 (en) * 2020-10-28 2023-11-28 Balchem Corporation Methods of increasing magnesium bioavailability and absorption

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6352713B1 (en) * 1999-12-01 2002-03-05 Drugtech Corporation Nutritional composition
US8303995B1 (en) * 2008-06-13 2012-11-06 Board Of Regents, The University Of Texas System Nitrite formulations and their use as nitric oxide prodrugs
US11241406B2 (en) * 2015-08-28 2022-02-08 Nature's Sunshine Products, Inc. Compositions and methods for acutley raising nitric oxide levels

Also Published As

Publication number Publication date
EP3829611A1 (en) 2021-06-09
EP3829611B1 (en) 2022-09-28
IT201800007747A1 (it) 2020-02-01
WO2020026187A1 (en) 2020-02-06
ES2933982T3 (es) 2023-02-15

Similar Documents

Publication Publication Date Title
IL275482A (en) Asketamine for the treatment of depression
IL276917A (en) A process for the preparation of alubixivet
EP3448874A4 (en) COMPOSITIONS FOR TREATING A DISEASE
ZA202006610B (en) Compositions for the treatment of skin conditions
GB201500314D0 (en) Pharmaceutical formulations for the treatment of pulmonary arterial hypertension
ZA202007055B (en) Compositions for the treatment of skin conditions
PT3573620T (pt) Composições para o tratamento da hipertensão
IL286000A (en) Asketamine for the treatment of depression
PL3376827T3 (pl) System przyrządzania co najmniej jednego produktu spożywczego
IL276592A (en) History of Subtirum
ZA202105111B (en) Pharmaceutical composition for the treatment of pulmonary arterial hypertension
IL282114A (en) Processes for preparing functionalized cyclooctenes
IL281720B2 (en) HMGB1 protein derivatives for biofilm removal
HUE063118T2 (hu) Eljárás N-alkil-nitrátoetilnitraminok elõállítására
SG11202005889WA (en) Process for the preparation of methyl mercaptan
IL291221A (en) Methods for the synthesis of wolbenzine
ZA202006591B (en) Compositions for the treatment of hypertension
EP3280332B8 (en) Indication of risk for coronary artery disease
EP3813872A4 (en) COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS
HUP1800278A2 (en) Process for the preparation of boc-linagliptin
HK40015207A (en) Compositions for the treatment of hypertension
GB201914617D0 (en) Nutraceutical composition
GB201901130D0 (en) Formulation for the treatment of tendinopathies
GB201714241D0 (en) Pharmaceutical compositions for the treatment of proteinopathies
PT3445377T (pt) Composições para a pele